Brief: Sensus Healthcare Announces Study Showing Single Low Dose Of Superficial Radiation Therapy Prevents Keloid Recurrence Following Surgical Excision
Dec 1 (Reuters) - Sensus Healthcare Inc SRTS.O :
* SENSUS HEALTHCARE ANNOUNCES STUDY SHOWING SINGLE LOW DOSE
OF
SUPERFICIAL RADIATION THERAPY PREVENTS KELOID RECURRENCE
FOLLOWING SURGICAL EXCISION
* SENSUS HEALTHCARE INC - SINGLE LOW DOSE OF SRT FOLLOWING
EXCISION OF 14 KELOIDS HAD AN APPROXIMATE 6.25% RECURRENCE RATE
AT SIX MONTHS
* SENSUS HEALTHCARE INC - FOR 10 PATIENTS AVAILABLE FOR
FOLLOW-UP
AT 24 MONTHS NONE OF KELOIDS HAD RECURRED
Source text for Eikon: ID:nGNX9l8QwL
Further company coverage: SRTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sensus Healthcare
See all newsSensus Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Sensus Healthcare Q2 revenue misses estimates as unit sales fall
Brief: Sensus Healthcare Q2 Net Income USD -8.749 Million
Sensus Healthcare Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Sensus Healthcare - Enters $15 Million Revolving Credit Facility With City National Bank Of Florida - SEC Filing